Navigation Links
Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone

cebo once-daily for 14 days (3 saxagliptin, 1 placebo ratio, n=8 subjects/dose panel).

Study 2 consisted of 50 healthy subjects (ages 18-45) who were randomized to receive 40, 100, 150, 200, 300 or 400 mg saxagliptin or matching placebo once daily for 14 days. Within each panel, 6 subjects received 100, 150, 200, 300 or 400 mg saxagliptin, 2 subjects received 40 mg saxagliptin and 2 subjects received matching placebo.

In both studies, there were no deaths or serious adverse events. Additionally, no adverse events of hypoglycemia were reported by investigators. In Study 2, one participant experienced an adverse event (mild rash), which resulted in discontinuation from the study while taking 200 mg of saxagliptin once daily.

About Type 2 Diabetes

Type 2 diabetes is the most common form of diabetes, accounting for approximately 90-95 percent of diabetes cases. Having Type 2 diabetes increases the risk of many serious complications, including heart disease or stroke, high blood pressure, amputation (particularly legs), blindness, nerve damage, and kidney failure. The risk of stroke and the rate of deaths due to heart disease are two to four times higher among people with diabetes, and about 65 percent of deaths among people with diabetes are due to heart disease and stroke.

The A1C test (also known as hemoglobin A1C) is used primarily to monitor the glucose control of diabetics over time. The goal of those with diabetes is to keep their blood glucose levels as close to normal as possible. This helps to minimize the complications caused by chronically elevated glucose levels, such as progressive damage to body organs like the kidneys, eyes, cardiovascular system, and nerves. The A1C test gives a picture of the average amount of glucose in the blood over the last few months. It can help a patient and his doctor know if the measures they are taking to control the patient's diabetes are successful or need to be adjusted.

About Saxag
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
2. Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic Control in Subjects with Type 2 Diabetes Compared to Metformin Alone
3. Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy
4. Study Demonstrated Rozerem (ramelteon) Does Not Affect Middle-of-the-Night Balance in Older Adults with Insomnia
5. Repros Reports That Proellex Has Demonstrated Superior Efficacy and Safety in Endometriosis When Compared to Standard of Drug Care
6. Organons Sugammadex Demonstrated a 9-12 Times Faster Recovery in Phase III Pivotal Trial as Compared to Neostigmine
7. Organons Sugammadex Demonstrated a 9-12 Times Faster Recovery in Phase III Pivotal Trial Compared to Neostigmine
8. Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free Response Across Multiple Attacks
9. Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
10. Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
11. 12-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA (methylphenidate transdermal system)

Post Your Comments:
(Date:11/25/2009)...5 Reportlinker.com announces that ...atalogue: ,, United States Dental Devices Mark...ww.reportlinker.com/p0158733/United-States-Dental-... ,, United States Dental Devices Market Analys...s report is an essential source for in-depth infor...
(Date:11/25/2009).... 25 Abaxis, Inc. (Nasda...ng point-of-care blood analysis systems, announced...cutive officer, will present at the 21st Annual Pi...ecember 2, 2009 at 2:00 p.m. ET. The conference wi...k City. ,, About Abaxis ,, Abaxis develop...
(Date:11/25/2009)...Nov. 25 According to Millennium Re...l technology market intelligence, the nearly $3 bi...ontinue to see rapid growth over the next five yea... Markets for Trauma Devices 2010 report finds t...e next five years, with competitors introducing sp...
Breaking Medicine Technology:Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 13US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Spectros Signs New International Distribution Deals 10635 1Spectros Signs New International Distribution Deals 10635 2Aware Inc Reports Third Quarter 2009 Financial Results 10632 1Aware Inc Reports Third Quarter 2009 Financial Results 10632 2Aware Inc Reports Third Quarter 2009 Financial Results 10632 3Aware Inc Reports Third Quarter 2009 Financial Results 10632 4Aware Inc Reports Third Quarter 2009 Financial Results 10632 5Aware Inc Reports Third Quarter 2009 Financial Results 10632 6Aware Inc Reports Third Quarter 2009 Financial Results 10632 7BIO key 28R 29 International Exhibiting at AABB TXPO 10629 1BIO key 28R 29 International Exhibiting at AABB TXPO 10629 2
...ith another stent hikes the risk of repeat blood ...March 29 When a clot develops inside a,coronary s...ially causing a,heart attack or even death. A sing... a new study suggests that one in six patients can... According to the Dutch Stent,Thrombosis Study, am...
...tor excel with high-dose clopidogrel on board?, C...ed,light on the ideal combination of medications f...hortly after percutaneous coronary intervention (P...etermine whether bivalirudin,a direct inhibitor of...ractionated heparin, an indirect thrombin inhibito...
Other Medicine Technology:Study Finds Repeated Episodes of Stent Thrombosis Common 2Study Finds Repeated Episodes of Stent Thrombosis Common 3ISAR-REACT 3 Pits Bivalirudin vs. Unfractionated Heparin in PCI 2ISAR-REACT 3 Pits Bivalirudin vs. Unfractionated Heparin in PCI 3
(Date:11/27/2009)... cycling plus low-emission vehicles may reduce fut...FRIDAY, Nov. 27 (HealthDay News) -- Encouraging ci...ars would offer much greater public health benefit...K. researchers have found. , The study compared...ve urban land transport scenarios for London, Engl...
(Date:11/27/2009)... Specialist manufacturers who use me...e saving millions of dollars by bringing in techno...Increasing numbers of pro-active medical manufactu...he concept stage of their projects, ensuring that ...n processes or potentially outdated technology. ,...
(Date:11/26/2009)...r sequestering drug tetrathiomolybdate (TM) has be...nt of Wilson disease, a disease caused by an overl...t much is known. Very little, however, is known ab... A new study led by Northwestern University resear...ee-dimensional structure of TM bound to copper-loa...
(Date:11/26/2009)... Research Triangle Dental (RTDental)... Carolina, today announced the expansion of its se...R Dentist, Dr. Doug Macmillan. , ... Dental is pleased to announce that Dr. Doug Macmi... completed an additional advanced training seminar...
(Date:11/25/2009)..., EMERYVILLE, Calif., Nov. 25 /PRNewswire-FirstCa... ) today announced that the company will host two ... ,, December 7, 2009 - 9:00 a.m. CT/10:00 a...s data presentations surrounding carfilzomib in re...ured at the 51st American Society of Hematology (A...
Breaking Medicine News(10 mins):Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2
...o protect all, studies show shots cut deaths, hosp...y News) -- The more people who get the flu vaccine...new studies. , In the first study, researchers fro...nce in 2000 helped lower flu-related deaths, hospi...
...ation and International Business Drive Top-Line Gr...er of Profitability, WESTFORD, Mass., Oct. 28 Cy... and manufacturer of a broad array of,light-based ...Results, Revenues increased to $38.2 million for ...
...nted Sunday, November 2, 2008 at this year,s liver... 31 - November 4, SAN FRANCISCO, Oct. 28 Researc..., led by Jennifer Kramer, Ph.D., looked at a,popul...us patients who have HIV are treated for HCV. This...
...., Oct. 28 Frost & Sullivan is,pleased to announc...ts 2008,Excellence in Healthcare Innovation Awards...at will take place on November 12, 2008 in San Ant...thcare.,Such companies have shown success at meeti...
...utive team has extensive medical device and financ...AIN VIEW, Calif., Oct. 28 PolyRemedy, Inc., a,man... fabrication and,tracking of customized, nano-mate... on October 14, 2008, and reports,directly to the ...
...NSUMERS LOOK TO MINIMALLY-INVASIVE PROCEDURES, CH...ooks matter for everyone from presidential candida...s forcing many consumers to re-evaluate,their cosm...ic meeting of the American Society of Plastic Surg...
Other Medicine News:Health News:When It Comes to Flu, the More Who Get Vaccine, the Better 2Health News:Cynosure Reports 21% Revenue Growth for the Third Quarter of 2008 2Health News:Cynosure Reports 21% Revenue Growth for the Third Quarter of 2008 3Health News:Cynosure Reports 21% Revenue Growth for the Third Quarter of 2008 4Health News:Cynosure Reports 21% Revenue Growth for the Third Quarter of 2008 5Health News:Cynosure Reports 21% Revenue Growth for the Third Quarter of 2008 6Health News:Cynosure Reports 21% Revenue Growth for the Third Quarter of 2008 7Health News:Cynosure Reports 21% Revenue Growth for the Third Quarter of 2008 8Health News:Cynosure Reports 21% Revenue Growth for the Third Quarter of 2008 9Health News:Cynosure Reports 21% Revenue Growth for the Third Quarter of 2008 10Health News:Cynosure Reports 21% Revenue Growth for the Third Quarter of 2008 11Health News:Why Are Some Veterans Who Are Coinfected With Hepatitis C and HIV More Likely to Be Treated for HCV Than Others? 2Health News:Frost & Sullivan to Present the 2008 Excellence in Healthcare Innovation Awards 2Health News:Frost & Sullivan to Present the 2008 Excellence in Healthcare Innovation Awards 3Health News:PolyRemedy Hires Gary Coughlen as CFO 2Health News:Consumers and Plastic Surgeons Say Economy Is Cutting Into Cosmetic Procedures 2Health News:Consumers and Plastic Surgeons Say Economy Is Cutting Into Cosmetic Procedures 3
EDM Ventricular Drainage Kit, with Drip Chamber
Lumbar External Drainage System (LED)
Monitorr ICP External CSF Drainage and Monitoring System
Skull Traction Tongs
Medicine Products: